|
Dapagliflozin 10mg Tab Clinical Trials
12 actively recruiting trials across 4 locations
Also known as: DAPA, Dapablix 10 mg, Farxiga, Forxiga, active drug +1 more
Pipeline
Phase 1: 1Phase 2: 3Phase 3: 3Phase 4: 3
Top Sponsors
- Yale University1
- University of Virginia1
- University of Oklahoma1
- University of Edinburgh1
- University of Colorado, Denver1
Indications
- Heart Disease8
- Diabetes3
- Myocardial Infarction2
- Atrial Fibrillation2
- Breast Cancer2
Other8 trials
Phase 3
Aurora, Colorado1 trial
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
University of Colorado Anschutz Medical Campus
Phase 4
New Haven, Connecticut1 trial
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
Yale New Haven Hospital-St. Raphael Campus
Phase 2
Oklahoma City, Oklahoma1 trial
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
University of Oklahoma Health Sciences Center
Phase 3
Charlottesville, Virginia1 trial
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
University of Virginia
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.